No Data
No Data
Abbott Laboratories Analyst Is Bullish About MedTech, Non-MedTech Growth
A Look Into Abbott Laboratories Inc's Price Over Earnings
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $130
Express News | Oppenheimer Initiates Coverage On Abbott Laboratories With Outperform Rating, Announces Price Target of $130
Oppenheimer Initiates Abbott Laboratories(ABT.US) With Buy Rating, Announces Target Price $130